Several studies have reported that BCL2 and proliferation activity are associated with histological prognostic parameters and patient prognosis in prostate cancer.31-34 We were unable to prove such correlation, which therefore makes these two parameters unreliable molecular predictors of prostate cancer behavior. This evidence concerns the gene BCL2 and prostate cancer.